Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Induced Pluripotent Stem Cells Carrying Monoamine Transporter Polymorphisms

NCT01534624 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT01534624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01534624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Induced Pluripotent Stem Cells Carrying Monoamine Transporter Polymorphisms
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Observational
Overall status
Completed
Start date
February 7, 2012
Completion date
July 30, 2014
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induced pluripotent stem cells